Medaus Compounding Pharmacy
Exposure to Room Light before Bedtime Suppresses Melatonin Onset and Shortens Melatonin Duration in Humans PDF Print E-mail

Context: Millions of individuals habitually expose themselves to room light in the hours before bedtime, yet the effects of this behavior on melatonin signaling are not well recognized.

Objective: We tested the hypothesis that exposure to room light in the late evening suppresses the onset of melatonin synthesis and shortens the duration of melatonin production.

Design: In a retrospective analysis, we compared daily melatonin profiles in individuals living in room light (<200 lux) vs. dim light (<3 lux).

Patients: Healthy volunteers (n = 116, 18–30 yr) were recruited from the general population to participate in one of two studies.

Setting: Participants lived in a General Clinical Research Center for at least five consecutive days.

Intervention: Individuals were exposed to room light or dim light in the 8 h preceding bedtime.

Outcome Measures: Melatonin duration, onset and offset, suppression, and phase angle of entrainment were determined.

Results: Compared with dim light, exposure to room light before bedtime suppressed melatonin, resulting in a later melatonin onset in 99.0% of individuals and shortening melatonin duration by about 90 min. Also, exposure to room light during the usual hours of sleep suppressed melatonin by greater than 50% in most (85%) trials.

Conclusions: These findings indicate that room light exerts a profound suppressive effect on melatonin levels and shortens the body's internal representation of night duration. Hence, chronically exposing oneself to electrical lighting in the late evening disrupts melatonin signaling and could therefore potentially impact sleep, thermoregulation, blood pressure, and glucose homeostasis.

Joshua J. Gooley*, Kyle Chamberlain, Kurt A. Smith, Sat Bir S. Khalsa, Shantha M. W. Rajaratnam, Eliza Van Reen, Jamie M. Zeitzer, Charles A. Czeisler, and Steven W. Lockley
Division of Sleep Medicine (J.J.G., K.A.S., S.B.S.K., S.M.W.R., E.V.R., J.M.Z., C.A.C., S.W.L.), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Faculty of Health and Medical Sciences (K.C.), University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom

This version published online on December 30, 2010
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2010-2098

Submitted on September 7, 2010
Accepted on November 22, 2010

* To whom correspondence should be addressed. E-mail: This e-mail address is being protected from spambots, you need JavaScript enabled to view it .

 

BBB SealHon Code
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

All Content © 2008 Medaus Pharmacy, Inc. & Other respective owners, All Rights Reserved. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician. Any medical or health advice provided and hosted on this site will only be given by medically trained and qualified professionals unless a clear statement is made that the advice offered is from a non-medically qualified individual or organisation. Where appropriate, information contained on this site will be supported by clear references to source data and, where possible, have specific HTML links to that data. The date when a clinical page was last modified will be clearly displayed.